Physician profile
Eric Castaneda
NPI 1225810427
$2,714.70
in general payments reported to CMS, 2019-2025
10 companies · $1,629 in 2025
The $1,629 reported for 2025 was more than what 90% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,086 · 2025: $1,629.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,715.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,714.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,217.95 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $364.92 | 2024-2025 | Dupixent |
| Amgen INC. | $278.86 | 2024-2025 | Otezla |
| Genzyme Corporation | $239.30 | 2024-2025 | |
| Ucb, INC. | $170.47 | 2025 | Bimzelx |
| Botanix Sb INC | $155.09 | 2025 | Sofdra |
| Arcutis Biotherapeutics, INC. | $98.86 | 2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $90.88 | 2024 | |
| Leo Pharma INC. | $82.88 | 2025 | |
| Galderma Laboratories, L.P. | $15.49 | 2025 | Aklief |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Castaneda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.